Cancer Research UK funds over 4,000 scientists, doctors and nurses who work to save more lives by preventing cancer, diagnosing it earlier and developing new and kinder treatments.
Cancer Research UK has been named the beneficiary of the 31st running of the J.P. Morgan Corporate Challenge at Battersea Park.
J.P. Morgan will donate in celebration of the Corporate Challenge to a registered charity that funds scientists, doctors and nurses to beat cancer sooner.
With one in two being diagnosed with cancer in their lifetime, Cancer Research UK’s mission is simple: To bring forward the day when all cancers are cured. Today two in four people survive cancer. As the world’s largest independent funder into cancer research, Cancer Research UK is uniquely positioned to achieve the goal of having three in four people survive cancer by 2034.
Cancer Research UK is a national charity with a local heart and a global impact. It funds over 4,000 scientists, doctors and nurses who work to save more lives by preventing cancer, diagnosing it earlier and developing new and kinder treatments. Its research has led to some of the biggest breakthroughs in cancer treatments such as advances in chemotherapy, radiotherapy and surgery. The research has a global impact and will be felt by people across the world.
Every day in London, around 90 people hear the words ‘you have cancer’. Last year, Cancer Research UK spent over £129 million on ground-breaking research in London. This has included clinical trials as well as world-leading advances being made at the Francis Crick institute and four Cancer Research UK Centres at University College London, Barts, Imperial College London and the Institute of Cancer Research. Its sharp-minded scientists in London helped pioneer the use of a new radiotherapy technique, known as Intensity Modulated Radiotherapy, which gives a more precise dose of radiation directly to the cancer cells and causes less damage to surrounding tissues which will result in fewer side effects for those receiving treatment. Research being carried out in London and all over the UK will help bring forward a day when all cancers are cured.
The 2017 J.P. Morgan Corporate Challenge in London will begin at 6.45 p.m. on Wednesday 5 July and Thursday 6 July. For the 11th consecutive year the race has achieved a full capacity of entrants with more than 28,000 total participants from approximately 775 companies.